全球吸药辅助器市场规模（按类型、分销管道、区域范围和预测）

吸药辅助器市场规模及预测

2024 年吸药辅助器市场规模价值 20.9 亿美元，预计到 2032 年将达到 26.3 亿美元，2026 年至 2032 年的复合年增长率为 3.21%。

储雾罐是一种用于提高气喘治疗定量吸入器 (MDI) 药效的装置。储雾罐通常由一根管子组成，一端连接到吸入器，另一端连接吸嘴或面罩。当药物从吸入器释放时，它会进入储雾罐，使使用者能够更缓慢、更深地吸入，从而改善药物向肺部的输送，并降低口腔溃疡等副作用的可能性。

对于那些难以协调使用吸入器的人来说，例如幼儿或有严重呼吸问题的人，储雾罐也特别有用，它们还可以帮助更多的药物到达呼吸道，而不会沉积在口腔和喉咙中。

吸药辅助器的全球市场动态

影响吸药辅助器市场的关键市场动态是：

关键市场驱动因素

全球气喘盛行率不断上升：全球气喘患者数量的不断增长是吸药辅助器市场的主要驱动力。根据世界卫生组织 (WHO) 的数据，2019 年气喘影响了约 2.62 亿人，夺走了 46.1 万人的生命。根据全球气喘网路 (Global Asthma Network) 发布的《2022 年全球气喘报告》，过去十年气喘盛行率上升了 3.6%。患者群体的不断扩大催生了对更有效的气喘控制技术（例如间隔器）的需求。

空气污染程度上升与环境诱因：空气污染加剧和环境变数加剧会加重气喘症状，因此需要使用储雾槽等有效的药物传递方式。根据世界银行的数据，每10人就有9人呼吸着污染的空气。根据2022年发表在《刺胳针星球健康》上的一项研究，空气污染每年导致儿童气喘病例增加180万例。空气品质与气喘发病之间的关联凸显了对储雾槽等气喘管理设备日益增长的需求。

提高对正确吸入技术的认识和教育：病患教育和对正确吸入技术的日益重视，正在推动使用储雾罐来改善药物输送并预防副作用。 2019年发表在《气喘杂誌》上的一项系统性回顾发现，只有31%的患者使用了正确的吸入技术。使用储雾罐可以显着改善药物分布。英国国家健康与照护卓越研究所 (NICE)建议所有使用压力定量吸入器 (pMDI) 的12岁以下儿童都应使用储雾槽。据英国哮喘协会称，正确使用储雾罐可以将药物输送到肺部的量提高10%至50%。

主要挑战

高成本：气喘储雾罐的高昂价格是市场面临的一大挑战。许多气喘患者，尤其是低收入患者，难以负担储雾罐的价格，从而限制了储雾罐的供应和可及性。这一成本障碍不仅影响个别患者，也限制了整个市场的成长，因为医疗保健提供者不愿意提案患者无法负担的产品。因此，有效的气喘控制技术往往未被充分利用。

来自替代设备的竞争：吸药辅助器市场面临来自雾化器和干粉吸入器 (DPI) 等替代设备的额外竞争。一些消费者和医疗保健提供者更青睐这些替代品。因此，吸药辅助器製造商必须努力突显其各自的优势，并确保满足患者和医疗保健系统不断变化的需求，从而实现产品差异化。这种竞争环境使间隔器製造商的市场定位和成长策略变得更加复杂。

主要趋势：

更重视预防性医疗保健：随着医疗保健系统更加重视在气喘等慢性疾病恶化之前进行治疗，气喘储雾罐已成为综合治疗方法的重要组成部分。这些装置可以改善药物输送，并减少气喘发作的次数和严重程度。这种向预防性干预的转变不仅改善了患者的预后，也满足了更大的医疗保健成本削减目标，从而增加了对储雾罐的需求。

新兴市场应用日益普及：随着气喘治疗意识的增强以及吸入疗法益处的不断增加，气喘高发地区对有效给药装置的需求日益增长。随着医疗基础设施的改善以及气喘控制产品可近性的提高，製造商正努力提高这些地区的渗透率。这些发展为吸药辅助器市场创造了巨大的成长机会。

目录

第一章吸药辅助器的全球市场介绍

• 市场介绍
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章吸药辅助器的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章 全球吸药辅助器市场（依类型）

• 概述
• 正排量
• 航空室
• 灵感
• 光学腔体
• 其他的

第六章全球吸药辅助器市场按分销管道

• 概述
• 医院
• 零售药局
• 线上通路

第七章全球吸药辅助器市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

8. 全球吸药辅助器市场的竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第九章 公司简介

• GlaxoSmithKline Plc.
• Trudell Medical International
• Conmed Corporation
• Medical Development International
• Royal Philips
• Clement Clarke International Ltd.
• Lupin Limited
• Vyaire Medical Inc.
• Pari GmbH
• AstraZeneca

第十章 重大进展

• 产品发布/开发
• 合併与收购
• 业务扩展
• 伙伴关係与合作

第十一章 附录

• 相关调查

Asthma Spacers Market Size And Forecast

Asthma Spacers Market size was valued at USD 2.09 Billion in 2024 and is projected to reach USD 2.63 Billion by 2032, growing at a CAGR of 3.21% from 2026 to 2032.

A spacer is a device that improves the efficiency of metered-dose inhalers (MDIs) used to deliver asthma treatments. It usually comprises a tube connected to the inhaler on one end and a mouthpiece or mask on the other. When the medication is released from the inhaler, it enters the spacer, allowing the user to inhale it more slowly and deeply, improving delivery to the lungs and lowering the chance of side effects such as mouth thrush.

Furthermore, spacers are especially useful for people who struggle to coordinate when using inhalers, such as young children or those who have severe breathing problems. They can also ensure that more medication reaches the airways instead of being deposited in the mouth and throat.

Global Asthma Spacers Market Dynamics

The key market dynamics that are shaping the Asthma Spacers Market include:

Key Market Drivers

Increasing Prevalence of Asthma Globally: The increasing number of asthma sufferers globally is a major driver of the Asthma Spacers Market, as these devices improve the efficacy of inhaled treatments. According to the World Health Organization (WHO), asthma affected an estimated 262 million people in 2019 and claimed 461,000 lives. According to the Global Asthma Network's Global Asthma Report 2022, the prevalence of asthma has increased by 3.6% over the last decade. This expanding patient group demands more effective asthma control techniques, such as spacers.

Rising Air Pollution Levels and Environmental Triggers: Increasing air pollution and environmental variables exacerbate asthma symptoms, necessitating the use of effective medicine delivery methods such as spacers. According to the World Bank, 9 out of every 10 individuals breathe polluted air. According to a 2022 study published in The Lancet Planetary Health, air pollution causes an additional 1.8 million asthma cases in children each year. The link between air quality and asthma incidence highlights the growing necessity of asthma management devices, such as spacers.

Increasing Awareness and Education about Proper Inhaler Technique: The increased emphasis on patient education and good inhaler technique is driving the use of spacers to improve medicine delivery and prevent adverse effects. A systematic evaluation published in the Journal of Asthma in 2019 discovered that only 31% of patients used the correct inhaler technique. The use of spacers can greatly increase medicine distribution. The UK's National Institute for Health and Care Excellence (NICE) advises spacers for all children under the age of 12 who use pressurized metered-dose inhalers (pMDIs). According to Asthma UK, correct usage of spacers can boost drug delivery to the lungs by 10% to 50%.

Key Challenges:

High Costs: The high cost of asthma spacers is a key challenge for the market. Many asthma sufferers, particularly in low-income areas, struggle to buy spacers, limiting their accessibility and utilization. This cost barrier not only affects individual patients but also limits overall market growth because healthcare providers are hesitant to propose products that patients can't buy. As a result, effective asthma control techniques are often underutilized.

Competition from Alternative Devices: The Asthma Spacers Market faces additional competition from alternative devices such as nebulizers and dry powder inhalers (DPIs). Some consumers and healthcare providers prefer these options because they are thought to be easier to use or more effective. As a result, asthma spacer producers must work hard to differentiate their products by emphasizing their distinct benefits and ensuring they satisfy the changing needs of patients and healthcare systems. This competitive environment complicates market positioning and growth strategies for spacer makers.

Key Trends:

Growing Focus on Preventive Healthcare: Asthma spacers are becoming essential to comprehensive treatment regimens as healthcare systems place a greater emphasis on treating chronic disorders like asthma before they escalate. These devices improve medicine administration, lowering the number and severity of asthma episodes. This shift toward preventative interventions not only improves patient outcomes but also corresponds with larger healthcare cost-cutting goals, increasing demand for spacers.

Increased Adoption in Emerging Markets: With increased awareness of asthma care and the benefits of inhalation therapy, there is a growing demand for effective delivery devices in areas with high asthma prevalence. As healthcare infrastructures improve and access to asthma control products increases, manufacturers are working on these areas to broaden their reach. This development creates considerable growth opportunities for the Asthma Spacers Market as more patients seek better ways to manage their condition.

Global Asthma Spacers Market Regional Analysis

Here is a more detailed regional analysis of the Asthma Spacers Market:

North America:

According to Verified Market Research, North America is estimated to dominate the Asthma Spacers Market over the forecast period. North America, particularly the United States, has a high asthma burden, which drives demand for asthma control devices such as spacers. According to the Centers for Disease Control and Prevention (CDC), over 25 million Americans had asthma in 2019, accounting for roughly one in every thirteen persons. This includes 5.1 million children. The CDC also says that asthma causes 1.6 million emergency department visits in the United States each year. These high numbers highlight North America's sizable market for asthma control products, including spacers.

Furthermore, the well-developed healthcare system and large healthcare expenditures in North America contribute to the increased adoption of medical devices such as asthma spacers. According to the Organisation for Economic Cooperation and Development (OECD), the United States spent 17.8% of its GDP on healthcare in 2021, the most of any OECD country. Canada's healthcare spending was likewise high, accounting for 11.3% of GDP. This high level of healthcare spending makes medical equipment like asthma spacers more accessible and widely used.

Asia Pacific:

The Asia Pacific region is estimated to exhibit the highest growth within the Asthma Spacers Market during the forecast period. The Asia Pacific region is rapidly urbanizing, resulting in increased air pollution, which is a major risk factor for asthma and promotes demand for asthma management devices such as spacers. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), Asia Pacific's urban population is expected to increase from 2.3 billion in 2019 to 3.5 billion in 2050. This urbanization is accompanied by deterioration in air quality. According to the World Health Organization (WHO), 98% of low- and middle-income cities in Asia Pacific with more than 100,000 people do not fulfill WHO air quality recommendations. The combination of urbanization and air pollution is anticipated to increase asthma prevalence, necessitating the use of appropriate management tools.

Furthermore, increased healthcare spending and improved healthcare infrastructure in the Asia Pacific are making medical equipment, such as asthma spacers, more accessible. According to the World Bank, health expenditure as a proportion of GDP in East Asia and the Pacific climbed from 6.4% in 2010 to 7.1% in 2019. In South Asia, it increased from 3.5% to 3.8% over the same period. This trend points to increased expenditure in healthcare, which is likely to improve access to asthma control devices such as spacers.

Global Asthma Spacers Market: Segmentation Analysis

The Asthma Spacers Market is segmented on the basis of Type and Distribution Channel.

Asthma Spacers Market, By Type

• Volumatic
• Aerochamber
• Inspirease
• Optichamber
• Others

Based on Type, the market is segmented into Volumatic, Aerochamber, Inspirease, Optichamber, and Others. The Aerochamber segment is estimated to dominate the Asthma Spacers Market due to its ability to improve medicine delivery from metered-dose inhalers (MDIs) to the lungs, hence enhancing asthma treatment outcomes. Aerochambers are built with characteristics that assist inhalation and reduce medicine waste, making them a popular choice among both healthcare providers and consumers. Their widespread acceptance and demonstrated efficacy continue to fuel their market dominance.

Asthma Spacers Market, By Distribution Channel

• Hospitals
• Retail Pharmacy
• Online Channel

Based on Distribution Channel, the market is segmented into Hospitals, Retail Pharmacy, and Online Channel. The retail pharmacy segment is estimated to dominate the Asthma Spacers Market during the forecast period due to consumers' increased preference for easy access to pharmaceuticals and tailored guidance from pharmacy professionals. Retail pharmacies offer a diverse choice of asthma spacer options, allowing patients to select from a variety of brands and varieties. Furthermore, the expansion of retail pharmacies during the pandemic has made asthma control equipment more accessible, consolidating their dominant position in the distribution channel landscape.

Key Players

• The "Asthma Spacers Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are GlaxoSmithKline Plc., Trudell Medical International, Conmed Corporation, Medical Development International, Royal Philips, Clement Clarke International Ltd., Lupin Limited, Vyaire Medical, Inc., Pari GmbH, AstraZeneca, Merck & Co.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Asthma Spacers Market Recent Developments
• In November 2023, the faculty of medicine at the National University of Science and Technology (NUST) in Zimbabwe announced the invention of a cheap spacer specifically for children. These spacers are meant to be supplied widely throughout Africa at a low cost, perhaps saving thousands of lives.
• In April 2021, Vyaire Medical Inc. (UK) announced the European launch of ArtiQ.PFT. ArtiQ.PFT is an artificial intelligence-powered automated tool for interpreting pulmonary function tests (PFTs). According to a multi-center study published in the European Respiratory Journal, the technology's algorithm identifies illness patterns in 82 percent of instances, but pulmonologists only identify 45 percent.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ASTHMA SPACERS MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ASTHMA SPACERS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ASTHMA SPACERS MARKET, BY TYPE

• 5.1 Overview
• 5.2 Volumatic
• 5.3 Aerochamber
• 5.4 Inspirease
• 5.5 Optichamber
• 5.6 Others

6 GLOBAL ASTHMA SPACERS MARKET, BY DISTRIBUTION CHANNEL

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Retail Pharmacy
• 6.4 Online Channel

7 GLOBAL ASTHMA SPACERS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL ASTHMA SPACERS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 GlaxoSmithKline Plc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Trudell Medical International
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Conmed Corporation
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Medical Development International
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Royal Philips
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Clement Clarke International Ltd.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Lupin Limited
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Vyaire Medical Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Pari GmbH
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 AstraZeneca
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research